# Huma

> Huma is a London-based digital health technology company that builds a regulated, modular software platform used by hospitals, pharmaceutical companies and governments to run remote patient monitoring, 'hospital at home', companion apps and decentralized clinical trials. Founded in 2011 as Medopad and rebranded to Huma in 2020, it combines predictive algorithms, digital biomarkers and real-world data with a no-code Huma Cloud Platform so partners can launch regulated, disease- and device-agnostic health apps. Its Software as a Medical Device holds EU MDR Class IIb, US FDA Class II and UK MHRA registrations, and its technology has reached thousands of hospitals and tens of millions of patients worldwide.

- **Founded:** 2011
- **Headquarters:** London, United Kingdom
- **Founders:** Dan Vahdat (Founder & CEO), Rich Khatib (Co-founder)
- **Team size:** ~600 employees
- **Products:** Huma Cloud Platform, Remote Patient Monitoring / Hospital at Home, Companion & Disease-Management Apps, Decentralized / Digital Clinical Trials, myGP (via iPLATO)
- **Notable:** In 2013, its Medopad system was cited as the first enterprise-class mobile health information system to receive CE approval., Only disease- and device-agnostic platform reported to hold EU MDR Class IIb, US FDA (510(k)) Class II clearance and UK MHRA Class IIb registration simultaneously., Doubled its hospital reach during the COVID-19 pandemic as demand for remote monitoring surged.

## Products & services

- **Huma Cloud Platform** — A regulated, no-code/low-code platform that lets partners configure and launch disease- and device-agnostic health apps, integrated with GenAI, without rebuilding regulatory foundations each time.
- **Remote Patient Monitoring / Hospital at Home** — Modular software that collects vitals, symptoms and wearable data at home so care teams can monitor patients across disease areas and reduce readmissions.
- **Companion & Disease-Management Apps** — Regulated apps such as GDm-Health (gestational diabetes) and myasthenia gravis support, used across primary and secondary care.
- **Decentralized / Digital Clinical Trials** — Digital-first research tools with digital biomarkers, predictive algorithms and real-world data used by pharma partners like AstraZeneca and Bayer.
- **myGP (via iPLATO)** — A UK patient-access app for booking, prescriptions, reminders and vitals, reaching millions of NHS primary-care patients.
- **Population Health & CVD AI Screening** — Tools for large-scale cardiovascular screening and population engagement used by health systems and pharma.

## Achievements

- In 2013, its Medopad system was cited as the first enterprise-class mobile health information system to receive CE approval.
- Only disease- and device-agnostic platform reported to hold EU MDR Class IIb, US FDA (510(k)) Class II clearance and UK MHRA Class IIb registration simultaneously.
- Doubled its hospital reach during the COVID-19 pandemic as demand for remote monitoring surged.
- Raised over $300M in total funding and reached healthtech unicorn status.
- Backed by major pharma and industrial strategics including AstraZeneca, Bayer, Hitachi, Samsung and Sony.
- Expanded into the US in 2025 via the acquisition of respiratory-monitoring firm Aluna, adding 150+ US health systems and clinics.

## Latest updates

- **2025-05** — Acquired US respiratory-monitoring company Aluna (Knox Medical Diagnostics) and announced a global M&A partnership with Eckuity Capital, expanding its US footprint by 150+ health systems and clinics.
- **2025-01** — Partnered with virtual-care platform Wheel to deliver direct-to-consumer healthcare solutions as a service.
- **2024-07** — Completed a Series D of over $80M and launched the GenAI-integrated Huma Cloud Platform, opening its regulated infrastructure to third parties.
- **2024-07** — Alongside the raise, Huma made a round of layoffs as it refocused on its platform strategy.

## Links

- Website: https://huma.com
- LinkedIn: https://www.linkedin.com/company/humaforhealth
- Twitter/X: https://twitter.com/humaforhealth
- Facebook: https://facebook.com/humaforhealth

---

Profile page: https://yespress.io/huma
Published by YesPress — https://yespress.io
Last updated: 2026-07-20